Veradigm Inc | MDRX - Cost Of Sales


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Veradigm Inc

Veradigm Inc reported $68.49M in Cost of Sales for its fiscal quarter ending in September of 2022.


Cost Of Sales Change
AmerisourceBergen ABC:US USD 61.16B 409.71M
Cardinal Health CAH:US USD 48.7B 1.1B
Catalent CTLT:US USD 762M 2M
Charles River Laboratories CRL:US USD 651.72M 49.24M
Computer Programs Systems CPSI:US USD 44.18M 1.9M
CVS Health CVS:US USD 51.46B 273M
General Electric GE:US USD 10.95B 4.81B
IQVIA Holdings Inc IQV:US USD 2.4B 9M
Laboratory Of America LH:US USD 2.8B 98.8M
Maximus MMS:US USD 978.25M 26.25M
McKesson MCK:US USD 65.84B 1.47B
Molina Healthcare MOH:US USD 6.87B 121M
Omnicell OMCL:US USD 165.6M 2.9M
Owens Minor OMI:US USD 2.03B 118.45M
Quest Diagnostics DGX:US USD 1.55B 6M
Veeva Systems VEEV:US USD 166.66M 2.35M
Veradigm Inc MDRX:US USD 68.49M 2.93M
Walgreens Boots Alliance WBA:US USD 27.81B 1.38B
Xerox XRX:US USD 1.13B 140M